D.NiemeyerE
And that comparison uses the enhanced version of phentermine, not phentermine alone, which performs worse
However, these versions of oral tirzepatide have not been approved by the FDA, and there is insufficient clinical data to demonstrate that oral tirzepatide works as effectively as the injectable formulation
Retatrutide produced clinically meaningful reductions in HbA1c across the dose range alongside body-weight loss of about 17% at the top dose, with a safety profile in line with GLP-1 and dual GIP/GLP-1 agonists [2]
Pooled data from seven randomized controlled trials involving 680 adult participants demonstrated meaningful weight-loss outcomes, with non-diabetic individuals achieving reductions of up to 8.44% and diabetic participants achieving approximately 3.55% weight loss over a 24-week periods
Our medical team tailors each plan to your biology, goals, and clinical needs following a comprehensive evaluation